Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan

Amy Body, Catherine Martin, View ORCID ProfileLucy Busija, View ORCID ProfileLuxi Lal, View ORCID ProfileElizabeth Ahern, View ORCID ProfileRaina C MacIntyre, View ORCID ProfileEva Segelov
doi: https://doi.org/10.1101/2023.02.26.23286261
Amy Body
1Monash University, Victoria, Australia
2Monash Health, Clayton, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Martin
1Monash University, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy Busija
1Monash University, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucy Busija
Luxi Lal
1Monash University, Victoria, Australia
2Monash Health, Clayton, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luxi Lal
Elizabeth Ahern
1Monash University, Victoria, Australia
2Monash Health, Clayton, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth Ahern
  • For correspondence: elizabeth.ahern{at}monash.edu
Raina C MacIntyre
3The Kirby Institute @ The University of New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raina C MacIntyre
Eva Segelov
1Monash University, Victoria, Australia
2Monash Health, Clayton, Victoria, Australia
4University of Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eva Segelov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

COVID-19 disease is associated with higher morbidity and mortality in cancer patients. Our study aimed to characterize the optimal strategy to improve vaccine induced protection against COVID-19 in children and adolescents with cancer. Results from The SerOzNET study will contribute comprehensive data on serology, cellular immune correlates from functional T-cell assays, quality of life data, and associated toxicity in relation to COVID-19 vaccination in children and adults with cancer.

In this plan, we describe the statistics that will be used to report results of the SerOzNET study. SerOzNET examines COVID-19 vaccine response in children and adolescents with cancer.

We have no conflicts of interest to disclose.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding support was received from Cancer Australia, Victorian Cancer Agency, The Leukaemia Foundation (Australia), and Monash Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Monash Health Human Research and Ethics Committee gave ethical approval for this work. Study Title: SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer [SerOzNET] HREC Reference Number: HREC/76506/MonH-2021-268415(v2) Monash Health Local Reference: RES-21-0000-337A ERM Project ID: 76506 research{at}monashhealth.org www.monashhealth.org/page/research

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

  • List of Abbreviations

    AE
    Adverse Event
    ATAGI
    Australian Technical Advisory Group on Immunization
    AZ
    Astra Zeneca
    CALD
    Culturally And Linguistically Diverse
    CDE
    Common Data Elements
    eCRF
    Electronic Case Report Form
    HREC
    Human Research Ethics Committee
    ICH-GCP
    International Conference on Harmonization Good Clinical Practice
    IgG
    Immunoglobulin G
    LBA
    Ligand Binding Assay
    Nab
    Neutralizing Antibody
    QoL
    Quality of Life
    PedsQL
    Pediatric Quality of Life Scale
    PRO-CTCAE
    Patient Reported Outcomes Common Terminology Criteria for Adverse Events
    MOGA
    Medical Oncology Group of Australia
    PEG
    Polyethylene glycol
    SAP
    Statistical Analysis Plan
    SARS
    CoV-2 Severe Acute Respiratory Syndrome Coronavirus Disease
    SerOzNET
    SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 01, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
    Amy Body, Catherine Martin, Lucy Busija, Luxi Lal, Elizabeth Ahern, Raina C MacIntyre, Eva Segelov
    medRxiv 2023.02.26.23286261; doi: https://doi.org/10.1101/2023.02.26.23286261
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
    Amy Body, Catherine Martin, Lucy Busija, Luxi Lal, Elizabeth Ahern, Raina C MacIntyre, Eva Segelov
    medRxiv 2023.02.26.23286261; doi: https://doi.org/10.1101/2023.02.26.23286261

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Oncology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)